The OncoSim-Cervix cancer microsimulation model: Unveiling roll-out strategies for human papillomavirus primary testing
Articles and reports: 82-003-X202501000002Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada. Issue Number: 2025010Author(s): Garner, Rochelle; Garaszczuk, Roxanne; Yong, Jean HE; Coldman, AndrewDOI: https://doi.org/10.25318/82-003-x202501000002-engMain Product:Health Reports
